Commonwealth Equity Services’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Commonwealth Equity Services’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,868	Closed	-$36K	–	3001
2019 Q4	$36K	Sell	2,868 -30	-1%	-$277	﹤0.01%	2824
2019 Q3	$30K	Hold	2,898	–	–	﹤0.01%	2776
2019 Q2	$49K	Hold	2,898	–	–	﹤0.01%	2699
2019 Q1	$97K	Hold	2,898	–	–	﹤0.01%	2603
2018 Q4	$84K	Buy	2,898 +1,000	+53%	+$44.4K	﹤0.01%	2513
2018 Q3	$116K	Hold	1,898	–	–	﹤0.01%	2620
2018 Q2	$140K	Buy	1,898 +9	+0.5%	+$701	﹤0.01%	2554
2018 Q1	$123K	Buy	1,889 +653	+53%	+$49.3K	﹤0.01%	2510
2017 Q4	$104K	Buy	1,236 +6	+0.5%	+$588	﹤0.01%	2509
2017 Q3	$142K	Buy	+1,230	New	+$129K	﹤0.01%	2369

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commonwealth Equity Services's BLCM Position: Q1 2020 in Review

Commonwealth Equity Services sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2020, closing a stake of 2,868 shares — an estimated $36K sold.

Commonwealth Equity Services first reported a position in BLCM in Q3 2017 and held it in 10 quarters. The position peaked at $142K in Q3 2017. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2020.

Commonwealth Equity Services reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Commonwealth Equity Services sold 2,868 Bellicum Pharmaceuticals, Inc. shares in Q1 2020, an estimated $36K.
Commonwealth Equity Services first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2017 and held it in 10 quarters.
Commonwealth Equity Services's Bellicum Pharmaceuticals, Inc. position peaked at $142K in Q3 2017.
29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2020.

Based on Commonwealth Equity Services's 13F filing for Q1 2020, filed 11 May 2020.